1. Wang, C., X. Wang, G. Gong, Q. Ben, W. Qiu, Y. Chen, G. Li, and L. Wang, Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer, 2012. 130(7): p. 1639-48.
2. Ben, Q., M. Xu, X. Ning, J. Liu, S. Hong, W. Huang, H. Zhang, and Z. Li, Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer, 2011. 47(13): p. 1928-37.
3. Ge, Z., Q. Ben, J. Qian, Y. Wang, and Y. Li, Diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies. Eur J Gastroenterol Hepatol, 2011. 23(12): p. 1127-35.
4. Jiang, Y., Q. Ben, H. Shen, W. Lu, Y. Zhang, and J. Zhu, Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol, 2011. 26(11): p. 863-76.
5. Larsson, S.C. and A. Wolk, Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia, 2011. 54(5): p. 1013-8.
6. Larsson, S.C., N. Orsini, K. Brismar, and A. Wolk, Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia, 2006. 49(12): p. 2819-23.
7. Friberg, E., N. Orsini, C.S. Mantzoros, and A. Wolk, Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia, 2007. 50(7): p. 1365-74.
8. Larsson, S.C., C.S. Mantzoros, and A. Wolk, Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 2007. 121(4): p. 856-62.
9. Tseng, C.H., C.K. Chong, C.P. Tseng, and T.T. Chan, Age-related risk of mortality from bladder cancer in diabetic patients: a 12-year follow-up of a national cohort in Taiwan. Ann Med, 2009. 41(5): p. 371-9.
10. Verlato, G., G. Zoppini, E. Bonora, and M. Muggeo, Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care, 2003. 26(4): p. 1047-51.
11. Heuson, J.C., N. Legros, and R. Heimann, Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Res, 1972. 32(2): p. 233-8.
12. Dubinett, S.M., J.M. Lee, S. Sharma, and J.J. Mule, Chemokines: can effector cells be redirected to the site of the tumor? Cancer J, 2010. 16(4): p. 325-35.
13. Gerstein, H.C., Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor. Ann Intern Med, 2004. 141(6): p. 475-6.
14. Khaw, K.T., N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day, Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med, 2004. 141(6): p. 413-20.
15. Khaw, K.T., N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day, Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev, 2004. 13(6): p. 915-9.
16. Stattin, P., O. Bjor, P. Ferrari, A. Lukanova, P. Lenner, B. Lindahl, G. Hallmans, and R. Kaaks, Prospective study of hyperglycemia and cancer risk. Diabetes Care, 2007. 30(3): p. 561-7.
17. Wellen, K.E. and G.S. Hotamisligil, Inflammation, stress, and diabetes. J Clin Invest, 2005. 115(5): p. 1111-9.
18. Nahman, N.S., Jr., K.L. Leonhart, F.G. Cosio, and C.L. Hebert, Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int, 1992. 41(2): p. 396-402.
19. Swartz, M.A. and A.W. Lund, Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer, 2012. 12(3): p. 210-9.
20. Lien, S.C., S.F. Chang, P.L. Lee, S.Y. Wei, M.D. Chang, J.Y. Chang, and J.J. Chiu, Mechanical regulation of cancer cell apoptosis and autophagy: roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK. Biochim Biophys Acta, 2013. 1833(12): p. 3124-33.
21. Shieh, A.C. and M.A. Swartz, Regulation of tumor invasion by interstitial fluid flow. Phys Biol, 2011. 8(1): p. 015012.
22. Ma, S., A. Fu, G.G. Chiew, and K.Q. Luo, Hemodynamic shear stress stimulates migration and extravasation of tumor cells by elevating cellular oxidative level. Cancer Lett, 2017. 388: p. 239-248.
23. Voelkel, N.F., C. Cool, S.D. Lee, L. Wright, M.W. Geraci, and R.M. Tuder, Primary pulmonary hypertension between inflammation and cancer. Chest, 1998. 114(3 Suppl): p. 225S-230S.
24. Xiong, N., S. Li, K. Tang, H. Bai, Y. Peng, H. Yang, C. Wu, and Y. Liu, Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways. Biochim Biophys Acta, 2017. 1864(1): p. 12-22.
25. Bin, G., W. Cuifang, Z. Bo, W. Jing, J. Jin, T. Xiaoyi, C. Cong, C. Yonggang, A. Liping, M. Jinglin, and X. Yayi, Fluid shear stress inhibits TNF-alpha-induced osteoblast apoptosis via ERK5 signaling pathway. Biochem Biophys Res Commun, 2015. 466(1): p. 117-23.
26. Suresh, S., Biomechanics and biophysics of cancer cells. Acta Biomater, 2007. 3(4): p. 413-38.
27. Zimmet, P., K.G. Alberti, and J. Shaw, Global and societal implications of the diabetes epidemic. Nature, 2001. 414(6865): p. 782-7.
28. International Diabetes Federation, 糖尿病概覽. 2014; Available from: http://www.idf.org/sites/default/files/attachments/DA6-update-poster-ZH.pdf.
29. 衛生福利部國民健康署. Available from: https://olap.hpa.gov.tw/Search.aspx?menu=100000000006&KeyWord=%E7%B3%96%E5%B0%BF%E7%97%85.
30. Chang, C., F. Lu, Y.C. Yang, J.S. Wu, T.J. Wu, M.S. Chen, L.M. Chuang, and T.Y. Tai, Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Res Clin Pract, 2000. 50 Suppl 2: p. S49-59.
31. Tseng, C.H., C.P. Tseng, C.K. Chong, T.P. Huang, Y.M. Song, C.W. Chou, S.M. Lai, T.Y. Tai, and J.C. Cheng, Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia, 2006. 49(8): p. 1755-60.
32. Chan, J.C., V. Malik, W. Jia, T. Kadowaki, C.S. Yajnik, K.H. Yoon, and F.B. Hu, Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA, 2009. 301(20): p. 2129-40.
33. Tseng, C.H., T.Y. Tai, C.K. Chong, C.P. Tseng, M.S. Lai, B.J. Lin, H.Y. Chiou, Y.M. Hsueh, K.H. Hsu, and C.J. Chen, Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect, 2000. 108(9): p. 847-51.
34. National Cancer Institute. [10 June 2014].
35. World Health Organization. February 2014 [10 June 2014].
36. Bruce Alberts, A.J., Julian Lewis, Martin Raff, Keith Roberts, and Peter Walter., Molecular Biology of the Cell, 4th edition. 2002.
37. Bhowmick, N.A., E.G. Neilson, and H.L. Moses, Stromal fibroblasts in cancer initiation and progression. Nature, 2004. 432(7015): p. 332-7.
38. Steeg, P.S., Tumor metastasis: mechanistic insights and clinical challenges. Nat Med, 2006. 12(8): p. 895-904.
39. Kasper, J.S. and E. Giovannucci, A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev, 2006. 15(11): p. 2056-62.
40. Flaveny, C.A., K. Griffett, D. El-Gendy Bel, M. Kazantzis, M. Sengupta, A.L. Amelio, A. Chatterjee, J. Walker, L.A. Solt, T.M. Kamenecka, and T.P. Burris, Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis. Cancer Cell, 2015. 28(1): p. 42-56.
41. Vigneri, P., F. Frasca, L. Sciacca, G. Pandini, and R. Vigneri, Diabetes and cancer. Endocr Relat Cancer, 2009. 16(4): p. 1103-23.
42. Yi-Jing Sheen, J.-L.L., W.H.-H. Sheu, Relationship between diabetes and cancer and the situation in Taiwan. Journal of Internal Medicine of Taiwan, February 2011.
43. Zhou, X.H., Q. Qiao, B. Zethelius, K. Pyorala, S. Soderberg, A. Pajak, C.D. Stehouwer, R.J. Heine, P. Jousilahti, G. Ruotolo, P.M. Nilsson, G. Calori, J. Tuomilehto, and D.S. Group, Diabetes, prediabetes and cancer mortality. Diabetologia, 2010. 53(9): p. 1867-76.
44. Hirakawa, Y., T. Ninomiya, N. Mukai, Y. Doi, J. Hata, M. Fukuhara, M. Iwase, T. Kitazono, and Y. Kiyohara, Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol, 2012. 176(10): p. 856-64.
45. Renehan, A.G., M. Zwahlen, C. Minder, S.T. O′Dwyer, S.M. Shalet, and M. Egger, Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet, 2004. 363(9418): p. 1346-53.
46. Garcia-Jimenez, C., J.M. Garcia-Martinez, A. Chocarro-Calvo, and A. De la Vieja, A new link between diabetes and cancer: enhanced WNT/beta-catenin signaling by high glucose. J Mol Endocrinol, 2014. 52(1): p. R51-66.
47. Knowles, M.A. and C.D. Hurst, Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer, 2015. 15(1): p. 25-41.
48. Ferlay, J., H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010. 127(12): p. 2893-917.
49. Hatina, J., W. Huckenbeck, H. Rieder, H.H. Seifert, and W.A. Schulz, [Bladder carcinoma cell lines as models of the pathobiology of bladder cancer. Review of the literature and establishment of a new progression series]. Urologe A, 2008. 47(6): p. 724-34.
50. Giovannucci, E., Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 2001. 131(11 Suppl): p. 3109S-20S.
51. Klement, R.J. and U. Kammerer, Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond), 2011. 8: p. 75.
52. Krone, C.A. and J.T. Ely, Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther, 2005. 4(1): p. 25-31.
53. Dankner, R., A. Chetrit, and P. Segal, Glucose tolerance status and 20 year cancer incidence. Isr Med Assoc J, 2007. 9(8): p. 592-6.
54. Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009. 324(5930): p. 1029-33.
55. Graham, N.A., M. Tahmasian, B. Kohli, E. Komisopoulou, M. Zhu, I. Vivanco, M.A. Teitell, H. Wu, A. Ribas, R.S. Lo, I.K. Mellinghoff, P.S. Mischel, and T.G. Graeber, Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol Syst Biol, 2012. 8: p. 589.
56. Dowling, R.J., S. Niraula, V. Stambolic, and P.J. Goodwin, Metformin in cancer: translational challenges. J Mol Endocrinol, 2012. 48(3): p. R31-43.
57. Yun, J., C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, K. Schmidt, J.K. Willson, S. Markowitz, S. Zhou, L.A. Diaz, Jr., V.E. Velculescu, C. Lengauer, K.W. Kinzler, B. Vogelstein, and N. Papadopoulos, Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science, 2009. 325(5947): p. 1555-9.
58. Heuson, J.C. and N. Legros, Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res, 1972. 32(2): p. 226-32.
59. Nerem, R.M., Tissue engineering: the hope, the hype, and the future. Tissue Eng, 2006. 12(5): p. 1143-50.
60. Rutkowski, J.M. and M.A. Swartz, A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol, 2007. 17(1): p. 44-50.
61. Jain, R.K., Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 2005. 307(5706): p. 58-62.
62. Mitchell, M.J. and M.R. King, Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol, 2013. 3: p. 44.
63. Shieh, A.C., H.A. Rozansky, B. Hinz, and M.A. Swartz, Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. Cancer Res, 2011. 71(3): p. 790-800.
64. Wallin, P. Cell microenvironment. Available from: https://patricwallin.wordpress.com/science/cell-microenvironment/.
65. Tse, J.M., G. Cheng, J.A. Tyrrell, S.A. Wilcox-Adelman, Y. Boucher, R.K. Jain, and L.L. Munn, Mechanical compression drives cancer cells toward invasive phenotype. Proc Natl Acad Sci U S A, 2012. 109(3): p. 911-6.
66. Cheng, G., J. Tse, R.K. Jain, and L.L. Munn, Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells. PLoS One, 2009. 4(2): p. e4632.
67. Helmlinger, G., P.A. Netti, H.C. Lichtenbeld, R.J. Melder, and R.K. Jain, Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol, 1997. 15(8): p. 778-83.
68. Koike, C., T.D. McKee, A. Pluen, S. Ramanujan, K. Burton, L.L. Munn, Y. Boucher, and R.K. Jain, Solid stress facilitates spheroid formation: potential involvement of hyaluronan. Br J Cancer, 2002. 86(6): p. 947-53.
69. Hofmann, M., M. Guschel, A. Bernd, J. Bereiter-Hahn, R. Kaufmann, C. Tandi, H. Wiig, and S. Kippenberger, Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model. Neoplasia, 2006. 8(2): p. 89-95.
70. Levental, K.R., H. Yu, L. Kass, J.N. Lakins, M. Egeblad, J.T. Erler, S.F. Fong, K. Csiszar, A. Giaccia, W. Weninger, M. Yamauchi, D.L. Gasser, and V.M. Weaver, Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell, 2009. 139(5): p. 891-906.
71. Chang, S.F., C.A. Chang, D.Y. Lee, P.L. Lee, Y.M. Yeh, C.R. Yeh, C.K. Cheng, S. Chien, and J.J. Chiu, Tumor cell cycle arrest induced by shear stress: Roles of integrins and Smad. Proc Natl Acad Sci U S A, 2008. 105(10): p. 3927-32.
72. Qazi, H., Z.D. Shi, and J.M. Tarbell, Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression. PLoS One, 2011. 6(5): p. e20348.
73. Munson, J.M. and A.C. Shieh, Interstitial fluid flow in cancer: implications for disease progression and treatment. Cancer Manag Res, 2014. 6: p. 317-28.
74. Wan, L., K. Pantel, and Y. Kang, Tumor metastasis: moving new biological insights into the clinic. Nat Med, 2013. 19(11): p. 1450-64.
75. Nguyen, D.X. and J. Massague, Genetic determinants of cancer metastasis. Nat Rev Genet, 2007. 8(5): p. 341-52.
76. Barcia, J.J., The Giemsa stain: its history and applications. Int J Surg Pathol, 2007. 15(3): p. 292-6.
77. Decherchi, P., P. Cochard, and P. Gauthier, Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer. J Neurosci Methods, 1997. 71(2): p. 205-13.
78. Takatani-Nakase, T., C. Matsui, S. Maeda, S. Kawahara, and K. Takahashi, High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLoS One, 2014. 9(2): p. e90136.
79. Takatani-Nakase, T., Migration behavior of breast cancer cells in the environment of high glucose level and the role of zinc and its transporter. Yakugaku Zasshi, 2013. 133(11): p. 1195-9.
80. Zhu, S., F. Yao, W.H. Li, J.N. Wan, Y.M. Zhang, Z. Tang, S. Khan, C.H. Wang, and S.R. Sun, PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion. Asian Pac J Cancer Prev, 2013. 14(10): p. 5687-92.
81. Normand Pouliot, H.B.P., and Allan Burrows., Investigating Metastasis Using In Vitro Platforms. Madame Curie Bioscience Database [Internet]. 2000-2013.
82. Lawler, K., G. Meade, G. O′Sullivan, and D. Kenny, Shear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3. Am J Physiol Cell Physiol, 2004. 287(5): p. C1320-7.
83. Yang, H., L. Guan, S. Li, Y. Jiang, N. Xiong, L. Li, C. Wu, H. Zeng, and Y. Liu, Mechanosensitive caveolin-1 activation-induced PI3K/AKT/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo. Oncotarget, 2016. 7(13): p. 16227-47.
84. YU-HSIANG LEE, C.-C.L., CHIEN-HSUN HUANG, FENG-MING HO, Laminar Shear Stress Promotes Nicotine-Induced Inflammation and Hemostatic Expression in Human Endothelial Cells. biomedical engineering society, 2016. 9.
85. Qian, Y., L. Corum, Q. Meng, J. Blenis, J.Z. Zheng, X. Shi, D.C. Flynn, and B.H. Jiang, PI3K induced actin filament remodeling through AKT and p70S6K1: implication of essential role in cell migration. Am J Physiol Cell Physiol, 2004. 286(1): p. C153-63.
86. Luo, J., B.D. Manning, and L.C. Cantley, Targeting the PI3K-AKT pathway in human cancer: rationale and promise. Cancer Cell, 2003. 4(4): p. 257-62.
87. Kim, C.S., V.V. Vasko, Y. Kato, M. Kruhlak, M. Saji, S.Y. Cheng, and M.D. Ringel, AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology, 2005. 146(10): p. 4456-63.
88. Guan, Z., X.R. Wang, X.F. Zhu, X.F. Huang, J. Xu, L.H. Wang, X.B. Wan, Z.J. Long, J.N. Liu, G.K. Feng, W. Huang, Y.X. Zeng, F.J. Chen, and Q. Liu, Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res, 2007. 67(21): p. 10436-44.
89. Manning, B.D. and L.C. Cantley, AKT/PKB signaling: navigating downstream. Cell, 2007. 129(7): p. 1261-74.
90. Liao, Y. and M.C. Hung, Physiological regulation of AKT activity and stability. Am J Transl Res, 2010. 2(1): p. 19-42.
91. Gingras, A.C., S.P. Gygi, B. Raught, R.D. Polakiewicz, R.T. Abraham, M.F. Hoekstra, R. Aebersold, and N. Sonenberg, Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev, 1999. 13(11): p. 1422-37.
92. Rosenwald, I.B., The role of translation in neoplastic transformation from a pathologist′s point of view. Oncogene, 2004. 23(18): p. 3230-47.
93. Cai, W., Q. Ye, and Q.B. She, Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail. Oncotarget, 2014. 5(15): p. 6015-27.
94. Fruhbeck, G., M. Lopez, and C. Dieguez, Role of caveolins in body weight and insulin resistance regulation. Trends Endocrinol Metab, 2007. 18(5): p. 177-82.
95. Quest, A.F., J.L. Gutierrez-Pajares, and V.A. Torres, Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med, 2008. 12(4): p. 1130-50.
96. Goetz, J.G., P. Lajoie, S.M. Wiseman, and I.R. Nabi, Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev, 2008. 27(4): p. 715-35.
97. Burgermeister, E., M. Liscovitch, C. Rocken, R.M. Schmid, and M.P. Ebert, Caveats of caveolin-1 in cancer progression. Cancer Lett, 2008. 268(2): p. 187-201.
98. Joshi, B., S.S. Strugnell, J.G. Goetz, L.D. Kojic, M.E. Cox, O.L. Griffith, S.K. Chan, S.J. Jones, S.P. Leung, H. Masoudi, S. Leung, S.M. Wiseman, and I.R. Nabi, Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res, 2008. 68(20): p. 8210-20.
99. Williams, T.M. and M.P. Lisanti, Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol, 2005. 288(3): p. C494-506.
100. Albinsson, S., I. Nordstrom, K. Sward, and P. Hellstrand, Differential dependence of stretch and shear stress signaling on caveolin-1 in the vascular wall. Am J Physiol Cell Physiol, 2008. 294(1): p. C271-9.
101. Frank, P.G. and M.P. Lisanti, Role of caveolin-1 in the regulation of the vascular shear stress response. J Clin Invest, 2006. 116(5): p. 1222-5.
102. Park, H., Y.M. Go, R. Darji, J.W. Choi, M.P. Lisanti, M.C. Maland, and H. Jo, Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am J Physiol Heart Circ Physiol, 2000. 278(4): p. H1285-93.
103. Wang, P., F. Zhu, Z. Tong, and K. Konstantopoulos, Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. FASEB J, 2011. 25(10): p. 3401-15.
104. Itoh, Y. and M. Seiki, MT1-MMP: an enzyme with multidimensional regulation. Trends Biochem Sci, 2004. 29(6): p. 285-9.
105. Itoh, Y., MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life, 2006. 58(10): p. 589-96.
106. Pahwa, S., M.J. Stawikowski, and G.B. Fields, Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression. Cancers (Basel), 2014. 6(1): p. 416-35.
107. Mori, H., T. Tomari, N. Koshikawa, M. Kajita, Y. Itoh, H. Sato, H. Tojo, I. Yana, and M. Seiki, CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J, 2002. 21(15): p. 3949-59.
108. Shiomi, T. and Y. Okada, MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev, 2003. 22(2-3): p. 145-52.
109. Uchibori, M., Y. Nishida, T. Nagasaka, Y. Yamada, K. Nakanishi, and N. Ishiguro, Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol, 2006. 28(1): p. 33-42.
110. Poincloux, R., F. Lizarraga, and P. Chavrier, Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci, 2009. 122(Pt 17): p. 3015-24.
111. Zhang, D. and P. Brodt, Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/AKT signaling. Oncogene, 2003. 22(7): p. 974-82.